Difference between revisions of "Template:Article of the week"

From LIMSWiki
Jump to navigationJump to search
(Updated article of the week text)
(Updated article of the week text.)
Line 1: Line 1:
<div style="float: left; margin: 0.5em 0.9em 0.4em 0em;">[[File:Fig2 DiNardo Toxins2020 12-4.png|240px]]</div>
<div style="float: left; margin: 0.5em 0.9em 0.4em 0em;">[[File:Fig2 Heinen BMCBioinfo2020 21.png|240px]]</div>
'''"[[Journal:Enzyme immunoassay for measuring aflatoxin B1 in legal cannabis|Enzyme immunoassay for measuring aflatoxin B1 in legal cannabis]]"'''
'''"[[Journal:HEnRY: A DZIF LIMS tool for the collection and documentation of biospecimens in multicentre studies|HEnRY: A DZIF LIMS tool for the collection and documentation of biospecimens in multicentre studies]]"'''


The diffusion of the legalization of [[wikipedia:Cannabis|cannabis]] for recreational, medicinal, and nutraceutical uses requires the development of adequate analytical methods to assure the safety and security of such products. In particular, [[wikipedia:Aflatoxin|aflatoxins]] are considered to pose a major risk for the health of cannabis consumers. Among analytical methods that allow for adequate monitoring of food safety, [[immunoassay]]s play a major role thanks to their cost-effectiveness, high-throughput capacity, simplicity, and limited requirement for equipment and skilled operators. Therefore, a rapid and sensitive [[enzyme immunoassay]] has been adapted to measure the most hazardous [[wikipedia:Aflatoxin B1|aflatoxin B<sub>1</sub>]] in cannabis products. The assay was acceptably accurate (recovery rate: 78–136%), reproducible (intra- and inter-assay means coefficients of variation 11.8% and 13.8%, respectively), and sensitive (limit of detection and range of quantification: 0.35 ng mL<sup>−1</sup> and 0.4–2 ng mL<sup>−1</sup> ... ('''[[Journal:Enzyme immunoassay for measuring aflatoxin B1 in legal cannabis|Full article...]]''')<br />
Well-characterized biological specimens (biospecimens) of high quality have great potential for the acceleration of and quality improvement in [[Translational research|translational biomedical research]]. To improve accessibility of local [[Sample (material)|specimen]] collections, efforts have been made to create central repositories ([[biobank]]s) and catalogues. Available technical solutions for creating professional local specimen catalogues and connecting them to central systems are cost intensive and/or technically complex to implement. Therefore, the HIV-focused Thematic Translational Unit (TTU) of the German Center for Infection Research (DZIF) developed a [[laboratory information management system]] (LIMS) called HIV Engaged Research Technology (HEnRY) for implementation into the HIV Translational Platform (TP-HIV) at the DZIF and other research networks. ('''[[Journal:HEnRY: A DZIF LIMS tool for the collection and documentation of biospecimens in multicentre studies|Full article...]]''')<br />
<br />
<br />
''Recently featured'':
''Recently featured'':
: ▪ [[Journal:Bringing big data to bear in environmental public health: Challenges and recommendations|Bringing big data to bear in environmental public health: Challenges and recommendations]]
: ▪ [[Journal:Enzyme immunoassay for measuring aflatoxin B1 in legal cannabis|Enzyme immunoassay for measuring aflatoxin B1 in legal cannabis]]
: ▪ [[Journal:The regulatory landscape of precision oncology laboratory medicine in the United States: Perspective on the past five years and considerations for future regulation|The regulatory landscape of precision oncology laboratory medicine in the United States: Perspective on the past five years and considerations for future regulation]]
: ▪ [[Journal:The regulatory landscape of precision oncology laboratory medicine in the United States: Perspective on the past five years and considerations for future regulation|The regulatory landscape of precision oncology laboratory medicine in the United States: Perspective on the past five years and considerations for future regulation]]
: ▪ [[Journal:Institutional ELN-LIMS deployment: Highly customizable ELN-LIMS platform as a cornerstone of digital transformation for life sciences research institutes|Institutional ELN-LIMS deployment: Highly customizable ELN-LIMS platform as a cornerstone of digital transformation for life sciences research institutes]]
: ▪ [[Journal:Health care and cybersecurity: Bibliometric analysis of the literature|Health care and cybersecurity: Bibliometric analysis of the literature]]

Revision as of 19:01, 3 August 2021

Fig2 Heinen BMCBioinfo2020 21.png

"HEnRY: A DZIF LIMS tool for the collection and documentation of biospecimens in multicentre studies"

Well-characterized biological specimens (biospecimens) of high quality have great potential for the acceleration of and quality improvement in translational biomedical research. To improve accessibility of local specimen collections, efforts have been made to create central repositories (biobanks) and catalogues. Available technical solutions for creating professional local specimen catalogues and connecting them to central systems are cost intensive and/or technically complex to implement. Therefore, the HIV-focused Thematic Translational Unit (TTU) of the German Center for Infection Research (DZIF) developed a laboratory information management system (LIMS) called HIV Engaged Research Technology (HEnRY) for implementation into the HIV Translational Platform (TP-HIV) at the DZIF and other research networks. (Full article...)

Recently featured:

▪ Bringing big data to bear in environmental public health: Challenges and recommendations
▪ Enzyme immunoassay for measuring aflatoxin B1 in legal cannabis
▪ The regulatory landscape of precision oncology laboratory medicine in the United States: Perspective on the past five years and considerations for future regulation
Retrieved from "https://www.limswiki.org/index.php?title=Template:Article_of_the_week&oldid=43529"